Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Seidman

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Oncology|May 8, 2001
The evolving role of gemcitabine in the management of breast cancerA D Seidman
Oncology (Williston Park, N.Y.)|March 17, 2001
Gemcitabine as single-agent therapy in the management of advanced breast cancerA D Seidman
Oncology (Williston Park, N.Y.)|March 28, 1998
One-hour paclitaxel via weekly infusion: dose-density with enhanced therapeutic indexA D Seidman
Breast Disease|February 3, 2005
Breast disease. IntroductionA D Seidman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
The emerging role of paclitaxel in breast cancer therapyA D Seidman
The Cancer Journal From Scientific American|November 1, 1995
Paclitaxel: the long and short of itA D Seidman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Single-agent use of Taxol (paclitaxel) in breast cancerA D Seidman
Seminars in Oncology|February 1, 1996
Chemotherapy for advanced breast cancer: a current perspectiveA D Seidman
Seminars in Oncology|July 14, 1999
Single-agent paclitaxel in the treatment of breast cancer: phase I and II developmentA D Seidman
Seminars in Oncology|August 1, 1997
Docetaxel and paclitaxel in breast cancer therapy: present status and future prospectsG M D'Andrea, A D Seidman
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Oncology|May 8, 2001
The evolving role of gemcitabine in the management of breast cancerA D Seidman
Oncology (Williston Park, N.Y.)|March 17, 2001
Gemcitabine as single-agent therapy in the management of advanced breast cancerA D Seidman
Oncology (Williston Park, N.Y.)|March 28, 1998
One-hour paclitaxel via weekly infusion: dose-density with enhanced therapeutic indexA D Seidman
Breast Disease|February 3, 2005
Breast disease. IntroductionA D Seidman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
The emerging role of paclitaxel in breast cancer therapyA D Seidman
The Cancer Journal From Scientific American|November 1, 1995
Paclitaxel: the long and short of itA D Seidman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Single-agent use of Taxol (paclitaxel) in breast cancerA D Seidman
Seminars in Oncology|February 1, 1996
Chemotherapy for advanced breast cancer: a current perspectiveA D Seidman
Seminars in Oncology|July 14, 1999
Single-agent paclitaxel in the treatment of breast cancer: phase I and II developmentA D Seidman
Seminars in Oncology|August 1, 1997
Docetaxel and paclitaxel in breast cancer therapy: present status and future prospectsG M D'Andrea, A D Seidman
Pageof 6